Improving phage therapy by evasion of phage resistance mechanisms
JAC-Antimicrobial Resistance · 28.12.2023 · 6 (1)
DOI: 10.1093/jacamr/dlae017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 09.02.2024. Verfasst von Inés Bleriot und 10 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Microbiología Traslacional y Multidisciplinar (MicroTM)-Servicio de Microbiología Instituto de Investigación Biomédica A Coruña (INIBIC), Ho…. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ISCIII, European Regional Development Fund, FEDER.
Abstract (Originalsprache)
Antibiotic failure is one of the most worrisome threats to global health. Among the new therapeutic efforts that are being explored, the use of bacteriophages (viruses that kill bacteria), also known as ‘phages’, is being extensively studied as a strategy to target bacterial pathogens. However, one of the main drawbacks of phage therapy is the plethora of defence mechanisms that bacteria use to defend themselves against phages. This review aims to summarize the therapeutic approaches that are being evaluated to overcome the bacterial defence systems, including the most innovative therapeutic approaches applied: circumvention of phage receptor mutations; modification of prophages; targeting of CRISPR-Cas systems and the biofilm matrix; engineering of safer and more efficacious phages; and inhibition of the anti-persister strategies used by bacteria.
Autor:innen und Institutionen
- Grupo de Microbiología Traslacional y Multidisciplinar (MicroTM)-Servicio de Microbiología Instituto de Investigación Biomédica A Coruña (INIBIC), Hospital A Coruña (CHUAC), Universidad de A Coruña (UDC), A Coruña, Spai…
- Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid, Spain.
- Microbiology and Parasitology Department Faculty of Medicine, UNAM, Mexico City, Mexico.
- Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, Belgium.
- Department of Chemical Engineering, Pennsylvania State University, University Park, PA, USA.
- MePRAM, Proyecto de Medicina de Precisión contra las resistencias Antimicrobianas, A Coruña, Spain.
ORCID-Profile: Lucia Blasco, Rodolfo García-Contreras, María Tomás
Förderung
- ISCIII
- European Regional Development Fund
- FEDER
- CIBERINFEC
- Ministerio de Ciencia e Innovación
- Miguel Servet Research Programme
- GAIN
- Xunta de Galicia
Zitieren
APA
Bleriot, I., Pacios, O., Blasco, L., Fernández-García, L., López, M., Ortiz-Cartagena, C., Barrio-Pujante, A., García-Contreras, R., Pirnay, J. P., Wood, T. K., & Tomás, M. (2023). Improving phage therapy by evasion of phage resistance mechanisms. JAC-Antimicrobial Resistance, 6(1). https://doi.org/10.1093/jacamr/dlae017
Vancouver
Bleriot I, Pacios O, Blasco L, Fernández-García L, López M, Ortiz-Cartagena C, et al. Improving phage therapy by evasion of phage resistance mechanisms. JAC-Antimicrobial Resistance. 2023;6(1). doi:10.1093/jacamr/dlae017
BibTeX
@article{Bleriot2023,
author = {Bleriot, Inés and Pacios, Olga and Blasco, Lucia and Fernández-García, Laura and López, María and Ortiz-Cartagena, Concha and Barrio-Pujante, Antonio and García-Contreras, Rodolfo and Pirnay, Jean-Paul and Wood, Thomas K and Tomás, María},
title = {Improving phage therapy by evasion of phage resistance mechanisms},
journal = {JAC-Antimicrobial Resistance},
year = {2023},
volume = {6},
number = {1},
doi = {10.1093/jacamr/dlae017}
}
EUVIMED